193 related articles for article (PubMed ID: 17692583)
1. Self-reinforced composites of bioabsorbable polymer and bioactive glass with different bioactive glass contents. Part II: In vitro degradation.
Niemelä T; Niiranen H; Kellomäki M
Acta Biomater; 2008 Jan; 4(1):156-64. PubMed ID: 17692583
[TBL] [Abstract][Full Text] [Related]
2. Self-reinforced composites of bioabsorbable polymer and bioactive glass with different bioactive glass contents. Part I: Initial mechanical properties and bioactivity.
Niemelä T; Niiranen H; Kellomäki M; Törmälä P
Acta Biomater; 2005 Mar; 1(2):235-42. PubMed ID: 16701800
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo behavior of self-reinforced bioabsorbable polymer and self-reinforced bioabsorbable polymer/bioactive glass composites.
Niiranen H; Pyhältö T; Rokkanen P; Kellomäki M; Törmälä P
J Biomed Mater Res A; 2004 Jun; 69(4):699-708. PubMed ID: 15162412
[TBL] [Abstract][Full Text] [Related]
4. Comparison of nanoscale and microscale bioactive glass on the properties of P(3HB)/Bioglass composites.
Misra SK; Mohn D; Brunner TJ; Stark WJ; Philip SE; Roy I; Salih V; Knowles JC; Boccaccini AR
Biomaterials; 2008 Apr; 29(12):1750-61. PubMed ID: 18255139
[TBL] [Abstract][Full Text] [Related]
5. New generation poly(ε-caprolactone)/gel-derived bioactive glass composites for bone tissue engineering: Part I. Material properties.
Dziadek M; Menaszek E; Zagrajczuk B; Pawlik J; Cholewa-Kowalska K
Mater Sci Eng C Mater Biol Appl; 2015 Nov; 56():9-21. PubMed ID: 26249560
[TBL] [Abstract][Full Text] [Related]
6. Fiber-reinforced bioactive and bioabsorbable hybrid composites.
Huttunen M; Törmälä P; Godinho P; Kellomäki M
Biomed Mater; 2008 Sep; 3(3):034106. PubMed ID: 18689925
[TBL] [Abstract][Full Text] [Related]
7. In vitro bioactivity and degradation of polycaprolactone composites containing silicate fillers.
Chouzouri G; Xanthos M
Acta Biomater; 2007 Sep; 3(5):745-56. PubMed ID: 17392042
[TBL] [Abstract][Full Text] [Related]
8. In vitro bioactivity and mechanical properties of bioactive glass nanoparticles/polycaprolactone composites.
Ji L; Wang W; Jin D; Zhou S; Song X
Mater Sci Eng C Mater Biol Appl; 2015 Jan; 46():1-9. PubMed ID: 25491953
[TBL] [Abstract][Full Text] [Related]
9. Degradation properties and ion release characteristics of Resilon and phosphate glass/polycaprolactone composites.
Borbely P; Gulabivala K; Knowles JC
Int Endod J; 2008 Dec; 41(12):1093-100. PubMed ID: 19133099
[TBL] [Abstract][Full Text] [Related]
10. Fabrication, characterization, and in vitro degradation of composite scaffolds based on PHBV and bioactive glass.
Li H; Du R; Chang J
J Biomater Appl; 2005 Oct; 20(2):137-55. PubMed ID: 16183674
[TBL] [Abstract][Full Text] [Related]
11. Effect of glass composition on the degradation properties and ion release characteristics of phosphate glass--polycaprolactone composites.
Prabhakar RL; Brocchini S; Knowles JC
Biomaterials; 2005 May; 26(15):2209-18. PubMed ID: 15585222
[TBL] [Abstract][Full Text] [Related]
12. In-situ polymerisation of fully bioresorbable polycaprolactone/phosphate glass fibre composites: In vitro degradation and mechanical properties.
Chen M; Parsons AJ; Felfel RM; Rudd CD; Irvine DJ; Ahmed I
J Mech Behav Biomed Mater; 2016 Jun; 59():78-89. PubMed ID: 26748261
[TBL] [Abstract][Full Text] [Related]
13. Premature degradation of poly(alpha-hydroxyesters) during thermal processing of Bioglass-containing composites.
Blaker JJ; Bismarck A; Boccaccini AR; Young AM; Nazhat SN
Acta Biomater; 2010 Mar; 6(3):756-62. PubMed ID: 19683603
[TBL] [Abstract][Full Text] [Related]
14. Sol-gel derived nanoscale bioactive glass (NBG) particles reinforced poly(ε-caprolactone) composites for bone tissue engineering.
Lei B; Shin KH; Noh DY; Jo IH; Koh YH; Kim HE; Kim SE
Mater Sci Eng C Mater Biol Appl; 2013 Apr; 33(3):1102-8. PubMed ID: 23827548
[TBL] [Abstract][Full Text] [Related]
15. In vitro Ca-P precipitation on biodegradable thermoplastic composite of poly(epsilon-caprolactone-co-DL-lactide) and bioactive glass (S53P4).
Jaakkola T; Rich J; Tirri T; Närhi T; Jokinen M; Seppälä J; Yli-Urpo A
Biomaterials; 2004 Feb; 25(4):575-81. PubMed ID: 14607495
[TBL] [Abstract][Full Text] [Related]
16. In vitro evaluation of poly(epsilon-caprolactone-co-DL-lactide)/ bioactive glass composites.
Rich J; Jaakkola T; Tirri T; Närhi T; Yli-Urpo A; Seppälä J
Biomaterials; 2002 May; 23(10):2143-50. PubMed ID: 11962655
[TBL] [Abstract][Full Text] [Related]
17. Development of a bioactive glass fiber reinforced starch-polycaprolactone composite.
Jukola H; Nikkola L; Gomes ME; Chiellini F; Tukiainen M; Kellomäki M; Chiellini E; Reis RL; Ashammakhi N
J Biomed Mater Res B Appl Biomater; 2008 Oct; 87(1):197-203. PubMed ID: 18386831
[TBL] [Abstract][Full Text] [Related]
18. Characterization of bioactive glass-reinforced HAP-polymer composites.
Greish YE; Brown PW
J Biomed Mater Res; 2000 Dec; 52(4):687-94. PubMed ID: 11033551
[TBL] [Abstract][Full Text] [Related]
19. Porous poly(alpha-hydroxyacid)/Bioglass composite scaffolds for bone tissue engineering. I: Preparation and in vitro characterisation.
Maquet V; Boccaccini AR; Pravata L; Notingher I; Jérôme R
Biomaterials; 2004 Aug; 25(18):4185-94. PubMed ID: 15046908
[TBL] [Abstract][Full Text] [Related]
20. Effect of long-term in vitro testing on the properties of bioactive glass-polysulfone composites.
Oréfice R; West J; Latorre G; Hench L; Brennan A
Biomacromolecules; 2010 Mar; 11(3):657-65. PubMed ID: 20108891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
